The estimated Net Worth of Capital Partners Iii, Llc L... is at least $5.79 Milion dollars as of 25 November 2019. Capital L owns over 937,000 units of Molecular Templates Inc stock worth over $5,751,993 and over the last 6 years Capital sold MTEM stock worth over $37,582.
Capital has made over 3 trades of the Molecular Templates Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Capital sold 3,496 units of MTEM stock worth $37,582 on 28 August 2020.
The largest trade Capital's ever made was buying 937,000 units of Molecular Templates Inc stock on 25 November 2019 worth over $7,496,000. On average, Capital trades about 326,374 units every 177 days since 2018. As of 25 November 2019 Capital still owns at least 4,198,535 units of Molecular Templates Inc stock.
You can see the complete history of Capital L stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 2825 Sand Hill Rd, Menlo Park, CA 94025, USA.
Over the last 7 years, insiders at Molecular Templates Inc have traded over $22,993,582 worth of Molecular Templates Inc stock and bought 14,744,530 units worth $82,519,716 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., David Hirsch oraz Capital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of $532,718. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth $587,500.
molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.
Molecular Templates Inc executives and other stock owners filed with the SEC include: